Preclinical activity of melflufen (J1) in ovarian cancer

Ovarian cancer carries a significant mortality. Since symptoms tend to be minimal, the disease is often diagnosed when peritoneal metastases are already present. The standard of care in advanced ovarian cancer consists of platinum-based chemotherapy combined with cytoreductive surgery. Unfortunately...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Carlier, Charlotte, Strese, Sara, Viktorsson, Kristina, Velander, Ebba, Nygren, Peter, Uustalu, Maria, Juntti, Therese, Lewensohn, Rolf, Larsson, Rolf, Spira, Jack, De Vlieghere, Elly, Ceelen, Wim P., Gullbo, Joachim
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2016
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5312315/
https://ncbi.nlm.nih.gov/pubmed/27528037
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11163
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires